InvestorsHub Logo
icon url

DesireToLearn

11/20/16 1:27 PM

#164370 RE: georgejjl #164369

Agree George. Also, I believe p2 success in P is a little different than B in antibiotic for many reasons, such as trial time and safety validation. Just as I suspect a successful p2 in B-OM will allow a tailwind behind B for partnership.